Breast biopsy patterns and findings among older women undergoing screening mammography: The role of age and comorbidity. Read more about Breast biopsy patterns and findings among older women undergoing screening mammography: The role of age and comorbidity.
SWOG 1918: A phase II/III randomized study of R-miniCHOP with or without oral azacitidine (CC-486) in participants age 75 years or older with newly diagnosed aggressive non-Hodgkin lymphomas - Aiming to improve therapy, outcomes, and validate a prospecti Read more about SWOG 1918: A phase II/III randomized study of R-miniCHOP with or without oral azacitidine (CC-486) in participants age 75 years or older with newly diagnosed aggressive non-Hodgkin lymphomas - Aiming to improve therapy, outcomes, and validate a prospecti
The impact of age on outcome in phase III NRG Oncology/RTOG trials of radiotherapy (XRT) +/- systemic therapy in locally advanced head and neck cancer. Read more about The impact of age on outcome in phase III NRG Oncology/RTOG trials of radiotherapy (XRT) +/- systemic therapy in locally advanced head and neck cancer.
Serial comprehensive geriatric and quality of life assessments in adults age ≥ 50 years undergoing autologous hematopoietic cell transplantation. Read more about Serial comprehensive geriatric and quality of life assessments in adults age ≥ 50 years undergoing autologous hematopoietic cell transplantation.
Toxicity and survival outcomes in older adults receiving concurrent or sequential chemoradiation for stage III non-small cell lung cancer in Alliance trials (Alliance A151812). Read more about Toxicity and survival outcomes in older adults receiving concurrent or sequential chemoradiation for stage III non-small cell lung cancer in Alliance trials (Alliance A151812).
Characterizing inclusion and exclusion criteria in clinical trials for chimeric antigen receptor (CAR) T-cell therapy among adults with hematologic malignancies. Read more about Characterizing inclusion and exclusion criteria in clinical trials for chimeric antigen receptor (CAR) T-cell therapy among adults with hematologic malignancies.
Use of geriatric assessment in hematopoietic cell transplant. Read more about Use of geriatric assessment in hematopoietic cell transplant.
P111 “NO ENERGY, ZIP”: A MIXED METHODS COMPARISON OF FUNCTIONAL DECLINE DURING IMMUNOTHERAPY, TARGETED THERAPY, AND/OR CHEMOTHERAPY IN OLDER ADULTS WITH NON-SMALL CELL LUNG CANCER (NSCLC). Read more about P111 “NO ENERGY, ZIP”: A MIXED METHODS COMPARISON OF FUNCTIONAL DECLINE DURING IMMUNOTHERAPY, TARGETED THERAPY, AND/OR CHEMOTHERAPY IN OLDER ADULTS WITH NON-SMALL CELL LUNG CANCER (NSCLC).
Do what you love. Love what you do. Dr. Arti Hurria's trailblazing transdisciplinary legacy. Read more about Do what you love. Love what you do. Dr. Arti Hurria's trailblazing transdisciplinary legacy.
Inflammatory biomarkers and patient-reported outcomes in acute myeloid leukemia: Refocusing on older adults. Read more about Inflammatory biomarkers and patient-reported outcomes in acute myeloid leukemia: Refocusing on older adults.
